Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at ...

The FDA has granted Fast Track designation to VS-041, an investigational therapy for the treatment of heart failure with preserved ejection fraction.

Mount Sinai study shows that traditional risk scores and symptoms such as chest pain should not be solely relied upon to ...

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

New analysis from landmark Phase 3 PRECISION trial published in the Journal of Hypertension highlights aprocitentan led to improvements in ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

Adults with atrial fibrillation and obesity/overweight (but no diabetes) who took the diabetes medication metformin after a rhythm correction procedure were more likely to stay free of AFib episodes ...

MINNEAPOLIS — Building on its initial success, researchers expanded a heart failure (HF) guideline-directed medical therapy clinic to treat more people with a wider range of left ventricular ejection ...

Panelists discuss how guideline-directed medical therapy has evolved to include 4-pillar treatment for heart failure with reduced ejection fraction (angiotensin-converting enzyme ...

Patients with heart failure (HF) often have difficulty obtaining life‐saving medications due to coverage barriers, such as prior authorizations and high out‐of‐pocket costs. To promote better coverage ...